Guided Therapeutics Stock Price History

GTHP Stock  USD 0.19  0.03  18.75%   
If you're considering investing in Guided OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Guided Therapeutics stands at 0.19, as last reported on the 30th of November, with the highest price reaching 0.19 and the lowest price hitting 0.19 during the day. Guided Therapeutics is out of control given 3 months investment horizon. Guided Therapeutics holds Efficiency (Sharpe) Ratio of 0.11, which attests that the entity had a 0.11% return per unit of risk over the last 3 months. We have analyze and collected data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.69% are justified by taking the suggested risk. Use Guided Therapeutics Market Risk Adjusted Performance of (2.00), risk adjusted performance of 0.1024, and Downside Deviation of 19.91 to evaluate company specific risk that cannot be diversified away.
  
Guided OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1076

Best PortfolioBest Equity
Good Returns
Average ReturnsGTHP
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 15.7
  actual daily
96
96% of assets are less volatile

Expected Return

 1.69
  actual daily
33
67% of assets have higher returns

Risk-Adjusted Return

 0.11
  actual daily
8
92% of assets perform better
Based on monthly moving average Guided Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Guided Therapeutics by adding it to a well-diversified portfolio.

Guided Therapeutics OTC Stock Price History Chart

There are several ways to analyze Guided Stock price data. The simplest method is using a basic Guided candlestick price chart, which shows Guided Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 28, 20240.2
Lowest PriceSeptember 18, 20240.12

Guided Therapeutics November 30, 2024 OTC Stock Price Synopsis

Various analyses of Guided Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Guided OTC Stock. It can be used to describe the percentage change in the price of Guided Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Guided OTC Stock.
Guided Therapeutics Price Rate Of Daily Change 1.19 
Guided Therapeutics Price Action Indicator 0.02 

Guided Therapeutics November 30, 2024 OTC Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Guided Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Guided Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Guided Stock and then apply it to test your longer-term investment strategies against Guided.

Guided OTC Stock Price History Data

The price series of Guided Therapeutics for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 0.08 with a coefficient of variation of 13.06. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.17. The median price for the last 90 days is 0.17. The company completed 1:800 stock split on 29th of March 2019. Guided Therapeutics completed dividends distribution on 2019-03-29.
OpenHighLowCloseVolume
11/30/2024
 0.19  0.19  0.19  0.19 
11/29/2024 0.19  0.19  0.19  0.19  125.00 
11/27/2024 0.16  0.16  0.16  0.16  100.00 
11/26/2024 0.20  0.20  0.16  0.19  3,000 
11/25/2024 0.16  0.19  0.16  0.16  11,674 
11/22/2024 0.19  0.19  0.16  0.19  5,400 
11/21/2024 0.18  0.18  0.18  0.18  100.00 
11/20/2024 0.20  0.20  0.20  0.20  1.00 
11/19/2024 0.17  0.20  0.17  0.20  2,800 
11/18/2024 0.18  0.18  0.18  0.18  501.00 
11/15/2024 0.17  0.17  0.17  0.17  1.00 
11/14/2024 0.17  0.17  0.16  0.17  6,202 
11/13/2024 0.20  0.20  0.20  0.20  12,900 
11/12/2024 0.15  0.18  0.15  0.18  3,700 
11/11/2024 0.20  0.20  0.20  0.20  3.00 
11/08/2024 0.19  0.20  0.15  0.20  4,300 
11/07/2024 0.16  0.16  0.16  0.16  1,000.00 
11/06/2024 0.18  0.18  0.16  0.16  11,800 
11/05/2024 0.20  0.20  0.16  0.20  4,997 
11/04/2024 0.15  0.20  0.15  0.20  6,500 
11/01/2024 0.19  0.19  0.16  0.16  600.00 
10/31/2024 0.16  0.20  0.16  0.20  5,754 
10/30/2024 0.15  0.16  0.14  0.16  101,100 
10/29/2024 0.17  0.17  0.16  0.16  43,327 
10/28/2024 0.18  0.23  0.17  0.20  130,191 
10/25/2024 0.17  0.18  0.17  0.18  10,500 
10/24/2024 0.17  0.17  0.17  0.17  500.00 
10/23/2024 0.17  0.17  0.16  0.16  10,200 
10/22/2024 0.17  0.17  0.16  0.16  17,800 
10/21/2024 0.16  0.16  0.16  0.16  10,400 
10/18/2024 0.14  0.15  0.13  0.15  6,505 
10/17/2024 0.18  0.18  0.18  0.18  6.00 
10/16/2024 0.14  0.18  0.14  0.18  3,100 
10/15/2024 0.14  0.14  0.14  0.14  1,500 
10/14/2024 0.13  0.14  0.13  0.14  2,000 
10/11/2024 0.18  0.18  0.13  0.13  2,000 
10/10/2024 0.16  0.16  0.16  0.16  2.00 
10/09/2024 0.16  0.16  0.16  0.16  1,200 
10/08/2024 0.13  0.18  0.13  0.18  2,075 
10/07/2024 0.18  0.18  0.18  0.18  1.00 
10/04/2024 0.18  0.18  0.18  0.18  1.00 
10/03/2024 0.14  0.18  0.14  0.18  800.00 
10/02/2024 0.14  0.18  0.14  0.18  3,300 
10/01/2024 0.16  0.18  0.12  0.12  1,400 
09/30/2024 0.12  0.18  0.12  0.18  2,500 
09/27/2024 0.17  0.17  0.17  0.17  3.00 
09/26/2024 0.18  0.18  0.12  0.17  20,200 
09/25/2024 0.16  0.16  0.16  0.16  710.00 
09/24/2024 0.15  0.15  0.14  0.14  3,500 
09/23/2024 0.16  0.16  0.16  0.16  1.00 
09/20/2024 0.13  0.16  0.13  0.16  710.00 
09/19/2024 0.13  0.16  0.13  0.16  710.00 
09/18/2024 0.12  0.12  0.12  0.12  1,300 
09/17/2024 0.19  0.19  0.19  0.19  501.00 
09/16/2024 0.15  0.15  0.15  0.15  4,624 
09/13/2024 0.19  0.19  0.19  0.19  110.00 
09/12/2024 0.17  0.17  0.17  0.17  2.00 
09/11/2024 0.16  0.20  0.14  0.17  6,600 
09/10/2024 0.16  0.16  0.16  0.16  5,200 
09/09/2024 0.13  0.13  0.13  0.13  1.00 
09/06/2024 0.13  0.13  0.12  0.13  11,100 

About Guided Therapeutics OTC Stock history

Guided Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Guided is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Guided Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Guided Therapeutics stock prices may prove useful in developing a viable investing in Guided Therapeutics
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia. Guided Therapeutics operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 5 people.

Guided Therapeutics OTC Stock Technical Analysis

Guided Therapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Guided Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Guided Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Sign In To Macroaxis Now

   

Sign In To Macroaxis

Sign in to explore Macroaxis' wealth optimization platform and fintech modules
All  Next Launch Module

Guided Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Guided Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Guided OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Guided to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Guided OTC Stock Analysis

When running Guided Therapeutics' price analysis, check to measure Guided Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guided Therapeutics is operating at the current time. Most of Guided Therapeutics' value examination focuses on studying past and present price action to predict the probability of Guided Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guided Therapeutics' price. Additionally, you may evaluate how the addition of Guided Therapeutics to your portfolios can decrease your overall portfolio volatility.